Estimating the length of hospitalization attributable to multidrug antibiotic resistance

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 9, 2010, Pages 4046-

  Blot, Stijn ^a   Vandijck, Dominique ^b   Lizy, Christelle ^b   Annemans, Lieven ^b   Vogelaers, Dirk ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTEREMIA; BLOOD CULTURE; COST BENEFIT ANALYSIS; CRITICALLY ILL PATIENT; ECONOMIC ASPECT; GRAM NEGATIVE INFECTION; HEALTH CARE COST; HOSPITAL INFECTION; LENGTH OF STAY; LETTER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HUMANS; TIME FACTORS;

EID: 77956101785     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00689-10     Document Type: Letter

References (6)

1. Blot, S. 2008. Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units. Clin. Microbiol. Infect. 14:5-13.
2. Blot, S., P. Depuydt, K. Vandewoude, and D. De Bacquer. 2007. Measuring the impact of multidrug resistance in nosocomial infection. Curr. Opin. Infect. Dis. 20:391-396.
3. Blot, S., K. Vandewoude, D. De Bacquer, and F. Colardyn. 2002. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin. Infect. Dis. 34:1600-1606.
4. Mauldin, P. D., C. D. Salgado, I. S. Hansen, D. T. Durup, and J. A. Bosso. 2010. Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria. Antimicrob. Agents Chemother. 54:109-115.
5. Vandijck, D. M., S. I. Blot, J. M. Decruyenaere, R. C. Vanholder, J. J. De Waele, N. H. Lameire, S. Claus, J. De Schuijmer, A. W. Dhondt, G. Verschraegen, and E. A. Hoste. 2008. Costs and length of stay associated with antimicrobial resistance in acute kidney injury patients with bloodstream infection. Acta Clin. Belg. 63:31-38.
6. Vandijck, D. M., M. Depaemelaere, S. O. Labeau, P. O. Depuydt, L. Annemans, F. M. Buyle, S. Oeyen, K. E. Colpaert, R. P. Peleman, S. I. Blot, and J. M. Decruyenaere. 2008. Daily cost of antimicrobial therapy in patients with intensive care unit-acquired, laboratory-confirmed bloodstream infection. Int. J. Antimicrob. Agents 31:161-165.